Author

Jack Satsangi 1

1 Gastrointestinal Unit,University of Edinburgh,Edinburgh,United Kingdom

ADALIMUMAB LONG-TERM EFFECTIVENESS IN ADALIMUMAB-NAIVE PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY

Edward V Loftus Jr, Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Remo Panaccione, Sofie Berg, Gabriela Alperovich, Mareike Bereswill, Jasmina Kalabic, Martha Skup, Joel Petersson, Anne M. Robinson

CD24-BASED ASSESSMENT OF NOD2-INFLUENCE ON PANETH-CELL NUMBERS USING INTESTINAL STEM CELL CULTURES AND GENETIC ASSOCIATION ANALYSIS OF CD24 IN IBD

Johan Van Limbergen, Kaoru Geddes, Paul Henderson, Richard K Russell, Hazel E. Drummond, Jack Satsangi, Anne Griffiths, Dana Philpott, David C. Wilson

COMPREHENSIVE CIRCULATORY TRANSCRIPTOME AND PROTEOMIC PROFILING IN NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES: A MULTI-CENTRE COHORT STUDY  

Rahul Kalla, AleT Adams, Jonas Lindstrom, Morten Harald Vatn, Jørgen Jahnsen, Petr Ricanek, Daniel Bergemalm, Johan D. Söderholm, Marieke J. Pierik, Fernando Gomollon Garcia, Mauro D'Amato, Jonas Halfvarson, Jack Satsangi

DYSBIOSIS OF THE GUT MICROBIOTA IN RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE

Petr Ricanek, Rahul Kalla, Yolanda Ber, simen vatn, Magdalena Kauczynska Karlsson, Lene Finnby, Daniel Bergemalm, Adam Carstens, Johan D. Söderholm, Jørgen Jahnsen, Fernando Gomollón, Jonas Halfvarson, Jack Satsangi, Christina Casén, Morten Harald Vatn

EPIGENETIC ALTERATIONS IN INFLAMMATORY BOWEL DISEASE - THE INFLUENCE OF GERMLINE VARIATION (MEQTLS) ON GENOME-WIDE METHYLATION ALTERATIONS.

AleT Adams, Rahul Kalla, Elaine R Nimmo, Morten Harald Vatn, Jørgen Jahnsen, Petr Ricanek, Jonas Halfvarson, Johan D. Söderholm, Marieke J. Pierik, Fernando Gomollon Garcia, Ivo G. Gut, Mauro D'Amato, Jack Satsangi

EPIGENOME-WIDE DNA METHYLATION PROFILING IN INFLAMMATORY BOWEL DISEASE

Nicholas T. Ventham, Nicholas Alexanader Kennedy, Alex T Adams, Rahul Kalla, Kate M O'Leary, Hazel E. Drummond, Elaine R Nimmo, David C. Wilson, Jack Satsangi

LONG-TERM EFFECTIVENESS OF ADALIMUMAB IN CROHN’S DISEASE: OBSERVATIONAL DATA FROM THE PYRAMID REGISTRY

Edward Loftus, Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Remo Panaccione, Roopal B Thakkar, Samantha Eichner, Majin M. Castillo, Natalia Kan-Dobrosky, Martha Skup, Parvez Mulani, Jingdong Chao

MICROBIOTA ALTERATIONS IN TREATMENT NAÏVE IBD AND NON-IBD PATIENTS - THE EU IBD-CHARACTER PROJECT

Petr Ricanek, simen vatn, Rahul Kalla, Yolanda Ber, Ewa Ciemniejewska, Marieke J. Pierik, Jonas Halfvarson, Johan D. Söderholm, Jørgen Jahnsen, Fernando Gomollon Garcia, Jack Satsangi, Morten Harald Vatn, Monika Sekelja, Christina Casén

NATURAL HISTORY CONFIRMS THE VALIDITY OF SEPARATING PAEDIATRIC IBD AT 10 YEARS OF AGE IN THE PARIS CLASSIFICATION

Johan Van Limbergen, Paul Henderson, Hazel E. Drummond, Richard K Russell, Jack Satsangi, David C. Wilson

PYRAMID REGISTRY: AN OBSERVATIONAL STUDY OF ADALIMUMAB IN CROHN’S DISEASE: RESULTS AT YEAR 5

Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Edward Loftus, Jr, Remo Panaccione, Majin M. Castillo, Natalia Kan-Dobrosky, Samantha Eichner, Roopal B Thakkar

Item 1 - 10 / 30
1
2 3